logo
logo
Sign in
Devanand Patil
Followers 39 Following 130
Devanand Patil 2022-07-18
With the advent of contingency plans across countries and financial institutions proposing relief plans, the automotive industry and in turn, the automotive axle market can make a strong comeback the COVID-19 impact. The types of automotive axle in the market include front axle as well as rear axle. Both these countries boast of an enormous automotive industry, which works in favor of the axle industry. Significant CompetitorsSignificant competitors in the automotive axle industry include Meritor Inc. It is said that 60 percent of the power distribution could go to the front axleAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
collect
0
Devanand Patil 2021-11-12
img

According to the report, the global photodynamic therapy market was valued at ~US$ 3 Bn in 2018, and is projected to expand at a CAGR of ~17% from 2019 to 2027.Read Report Overview - https://www.transparencymarketresearch.com/photodynamic-therapy-market.html Global Photodynamic Therapy Market: Key InsightsPhotodynamic therapy is a part of treatment that uses drugs and devices for the treatment of different chronic diseases such as cancer and malignant musculoskeletal tumors.Increase in the prevalence as well as incidence of cancer and skin diseases, growth in the number of surgeries, and approval of new biologics are major factors anticipated to drive the global photodynamic therapy market during the forecast period.According to the National Cancer Institute of the U.S., around 1,735,350 new cancer cases were diagnosed in the U.S. in 2018.

The USPTO granted a patent titled as ‘Metal-based Thiophene Photodynamic Compounds and their Use.’The photodynamic therapy market in Asia Pacific is expected to expand at a high CAGR of ~18%from 2019 to 2027, due to surge in the number of patients with psoriasis and acne, and rise in the demand for innovative cosmetic therapies in India, China, and South Korea.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=69615Rise in Prevalence of Skin Diseases to Drive Global Photodynamic Therapy MarketRise in the prevalence of skin diseases, worldwide, is projected to drive the global photodynamic therapy market during the forecast period.Acne is considered one of the most common skin conditions in the U.S., which affects over 50 millionpeople in the country every year.

Its prevalence is known to be higher among women, affecting over 15% of the total population of adult women.Psoriasis is known to affect over5 million people in the U.S. every year, with a higher rate of prevalence among people aged between 45 and 64 years.

This significant rise in the prevalence of skin diseases and the economic burden of these diseases generate high demand for photodynamic therapy, which is a cost-effective option.Request COVID Analysis on Photodynamic Therapy Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=69615Photosensitizers Drugs Dominate Global Photodynamic Therapy MarketIncrease in the number of clinical trials for the development of new photosensitizers, rise in the number of market players strengthening their research and development activities, and increase in expenditure on new drug development are various factors expected to drive the drugs segment during the forecast period.In September 2018, Health Canada approved the clinical trial application (CTA) filed by Theralase Technologies Inc., allowing clinical study evaluation of Theralase’s lead anti-cancer drug, i.e.

TLD-1433.Cancer the Most Prominent Application in Photodynamic Therapy MarketIn terms of application, the global photodynamic therapy market has been segmented into cancer, actinic keratosis (AK), psoriasis, acne, and others.

In October 2019, Theralase Technologies Inc. was granted a patent in Europe for its anti-cancer light-activated photodynamic compounds (PDCs).Request Customization on Photodynamic Therapy Market Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=69615Hospitals a Promising End User of Global Photodynamic Therapy MarketIn terms of end user, the global photodynamic therapy market has been categorized into hospitals, cosmetics & dermatology clinics, cancer treatment centers, and others.The cosmetics & dermatology clinics segment is likely to gain significant market share by 2027.

collect
1
Devanand Patil 2021-11-12
img

Thoracic Drainage Devices Market: Key FindingsTransparency Market Research has published a new report on the global thoracic drainage devices market.

The segment is likely to continue to dominate the market during the forecast period, owing to an increase in the adoption of thoracic drainage systems in hospitals due to a rise in the demand for surgical procedures.

A thoracic drainage system also offers advanced technological benefits such as portability and new generation of smaller user-friendly digital systems and additional safety features.In terms of application, the thoracic surgery & pulmonology segment is anticipated to account for a major share of the global thoracic drainage devices market.

Thoracic and pulmonological disorders are quite common, and the prevalence of these disorders is increasing.

It is caused due to collection of air in the chest cavity, which gets resolved on its own; however, most often, it requires hospital admission and urgent medical care.Rise in product recalls owing to improper packaging and malfunction, shortage of physicians, and challenges in maintaining chest tube patency are expected to hamper the growth of the global thoracic drainage devices market during the forecast period.Request Customization on Thoracic Drainage Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=40529Global Thoracic Drainage Devices Market: Prominent RegionsNorth America held a major share of the global thoracic drainage devices market in 2018.

Additionally, R activities being carried out to introduce new thoracic drainage devices with improved design and technology by a large number of market players in North America are driving the thoracic drainage devices market in the region.Europe held a significant market share in 2018, after North America.

collect
1
Devanand Patil 2021-11-11
img

Sepsis Treatment Market: IntroductionAccording to the report, the global sepsis treatment market was valued over US$ 600 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

Sepsis is a life threatening disease caused when a chemical develops in the immune system and is released into the bloodstream.

According to the Centers for Disease Control and Prevention, over 1.5 million cases of sepsis are reported globally each year.

Increase in the population above 65 years of age asserts the need of safe and effective therapeutics for sepsis treatment.

Leading pharmaceutical companies focus on addressing these unmet medical needs through new product development.

According to research, increase in geriatric population leads to rise in prevalence of atrial fibrillation and other cardiac diseases.

collect
2
Devanand Patil 2021-11-12
img

Respiratory Monitoring Devices Market: IntroductionRespiratory monitoring plays a significant role in the management of patients with respiratory diseases, such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma, among other diseases.

There are a number of technologically advanced respiratory monitoring devicesavailable in the market for personal use, intensive care, and inpatient settings.Increase in the prevalence of respiratory diseases, such as asthma, cystic fibrosis, and COPD, and rising geriatric population are major factors that are anticipated to drive the global respiratory monitoring devices market during the forecast periodRequest Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1415According to the World Health Organization, the global geriatric population was approximately 524 millionin- and is anticipated to reach 5 billion by 2050.

Moreover, world population is aging at a rapid pace, especially people in developed nations such as the U.S., Germany, and Japan.North America held a leading share of the global respiratory monitoring devices market in 2018due to the increase in the number of asthma cases and favorable medical schemes and reimbursement policiesAccording to the Behavioral Risk Factor Surveillance System (BRFSS) survey, in 2017, nearly 9 millionadults in the U.S. had asthma and around 16.3 million adults were diagnosed with COPD.

The survey also stated that nearly 33.2 million adults had chronic lung diseases.The respiratory monitoring devices market in Asia Pacific is expected to expand at a high CAGR of ~7%from 2019 to 2027 due to the growing healthcare expenditure, increasing prevalence of respiratory disorders, and improving healthcare infrastructureRequest COVID Analysis on Respiratory Monitoring Devices Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1415Rise in Prevalence Rate of Respiratory Diseases to Drive Respiratory Monitoring Devices MarketRise in prevalence rate of respiratory diseases worldwide is projected to drive the global respiratory monitoring devices market during the forecast periodApproximately 50% of Latin American countries reported that around 15%of the population suffered from childhood asthma, revealed by Forno and Colleagues in the journal Thorax published in December 2016According to the WHO, in 2015, globally, there were 100 million people affected with chronic respiratory diseases with sleep apnea being the most common problemRequest Customization on Respiratory Monitoring Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=1415Increase in Use of Pulse Oximeters in Clinics and LaboratoriesIn terms of product, the global respiratory monitoring devices market has been segmented into pulse oximeters, capnographs, spirometers, polysomnographs (PSG), peak flow meters, gas analyzers, and others.

The pulse oximeter segment accounted for a major market share in 2018.Technological advancements related to respiratory monitoring equipment and high utilization of pulse oximeters in clinics and laboratories are various factors that are likely to drive the pulse oximeters segment during the forecast periodRise in demand for non-invasive respiratory monitors is expected to accelerate the growth of the global respiratory monitoring devices marketIn November 2015, Montefiore Medical Center developed a non-invasive pulseless oximeter, which measures arterial oxygenation in patients with weak pulseHospitals to be Major End User of Respiratory Monitoring DevicesBased on end user, the global respiratory monitoring devices market has been categorized into home care, hospitals, ambulatory surgical centers, and specialty clinicsThe home care segment is likely to gain significant market share by Growth of this segment can be attributed to the increase in the adoption of respiratory monitoring devices for home use, rise in the number of market players launching portable devices, and growing demand for home use spirometers and peak flow meters.Buy Respiratory Monitoring Devices Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=1415=SNorth America to Lead Respiratory Monitoring Devices MarketIn terms of region, the global respiratory monitoring devices market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

North America is projected to account for a leading share of the global respiratory monitoring devices market during the forecast period, owing to the increase in the number of market players receiving FDA approval, new product launches, and significant growth of diagnostic medical devices market.In January 2019,Masimo received the FDA approval for MightSat Rx finger pulse oximeter that can be used at home, thereby expanding its share of the respiratory monitoring devices marketIn June 2015,Cohero Health received the FDA approval for mobile connected spirometer, a Bluetooth-connected device the measures critical lung functionGrowth Strategies of Key PlayersKey players operating in the global respiratory monitoring devices market are Medtronic, Philips Healthcare (Koninklijke Philips N.V.), Smiths Medical (part of Smiths Group plc), Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Welch Allyn, Inc. (Hill-Rom Holdings, Inc.), Masimo, MGC Diagnostics Corporation, Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture), Nihon Kohden Corporation, and Novelda ASLaunch of products for home use and increase in research and development activities by prominent players are major strategies adopted by companies operating in the respiratory monitoring devices marketGlobal Respiratory Monitoring Devices Market: SegmentationRespiratory Monitoring Devices Market, by ProductPulse OximetersCapnographsSpirometersPolysomnographs (PSG)Peak Flow MetersGas AnalyzersOthersRespiratory Monitoring Devices Market, by End UserHome careHospitalsAmbulatory Surgical CentersSpecialty Clinics Respiratory Monitoring Devices Market, by RegionNorth AmericaS.CanadaEuropeGermanyK.FranceSpainItalyRest of EuropeAsia PacificJapanChinaIndiaAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC CountriesSouth AfricaRest of Middle East & AfricaAbout UsTransparency Market Research is a global market intelligence company providing global business information reports and services.

collect
1
Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report on the systemic lupus erythematosus treatment market for the forecast period of 2019–2027.

According to the report, the global systemic lupus erythematosus treatment market was valued at ~US$ 1.7 Bn in 2018, and is projected to expand at a CAGR of ~7% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=73932Systemic Lupus Erythematosus Treatment Market: OverviewGrowth of the global systemic lupus erythematosus treatment market can be attributed to rise in the incidence of systemic lupus erythematosus, and promising drug pipeline and approvals.North America dominated the global systemic lupus erythematosus treatment market in 2018, and the trend is anticipated to continue during the forecast period.

).The immunosuppressive drugs segment dominated the global systemic lupus erythematosus treatment market in 2018, and the trend is likely to continue during the forecast period.Immunosuppressive drugs such as azathioprine, cyclophosphamide, and methotrexate help control inflammation and the overactive immune system in the treatment of SLE.

This, in turn, is projected to drive the segment during the forecast period.Furthermore, major market players are focusing on the launching of new products in the tablet and capsule form.

Moreover, drug degradation is less as compared to the oral route of administration.Retail Pharmacies Accounted for Major Share of MarketBased on distribution channel, the global systemic lupus erythematosus treatment market has been segmented into hospital pharmacies, retail pharmacies, and online sales.The retail pharmacies segment dominated the global systemic lupus erythematosus treatment market in terms of revenue in 2018,and the trend is projected to continue during the forecast period.

Increase in the number of retail pharmacy stores across the globe, availability of new products in retail stores, and availability of most of the drugs, such as NSAIDS, antimalarial drugs, and corticosteroids, as OTC drugs in retail stores, are likely to propel this segment during the forecast period.Hospital pharmacies is expected to be the second-most lucrative segment of the global systemic lupus erythematosus treatment market during the forecast period.

collect
1
Devanand Patil 2021-11-12
img

Due to rising prostate issues including growth of major issues like prostate cancer, the market will likely reach US 12 billion in valuation by 2027.

The new cases of prostate ailments and minimally surgical procedures as well as potency and efficacy of the new drugs will drive growth of the benign prostatic hyperplasia treatment market.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=72273The rise of the disease among middle-aged men is a newly discovered and growing cause of concern in the healthcare sector.

The surrounding campaigns like national prostate health month, and rising awareness of the disease in the region are expected to create new opportunities for players in the benign prostatic hyperplasia treatment market.Request COVID Analysis on Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=72273Rising Cases Presents a Major Challenge for the Healthcare SectorCurrently, BPH presents the most common form of benign among various tumor cases.

It is estimated that there are over 8 million American men who are suffering from the condition and 22 million patients suffer its mild symptoms.

Moreover, the growth of the tumor can make it difficult to operate on other serious ailments like prostate cancer among people above 90, whose risks is as high as 60%.Request Customization on Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Report –  https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=72273Rising Elderly Population to Drive Robust Growth GloballyRising geriatric population globally is expected to create significant opportunities for expansion for existing players in the market.

The population is also expected to rise at the fastest rate in the US, Japan, UK, China, Brazil, among others.

collect
1
Devanand Patil 2021-11-11
img

Intravascular Ultrasound (IVUS) Devices Market: IntroductionAccording to the report, the global intravascular ultrasound (IVUS) devices market was valued at US$ 600 Mn in 2020.

It helps to determine the amount of plaque buildup in a vessel and its composition.

Rise in the need of IVUS procedures during PCI procedures and increase in the adoption of IVUS systems in hospitals and diagnostic centers are key factors that are likely to drive the global intravascular ultrasound (IVUS) devices market during the forecast period.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=2208North America held a major share of the global intravascular ultrasound (IVUS) devices market in 2020, owing to the availability of skilled doctors, well-established healthcare facilities, and high healthcare expenditure.

The intravascular ultrasound (IVUS) devices market in Asia Pacific is projected to expand at a notable CAGR of 8.5% from 2021 to 2031, owing to a surge in patient pool and rise in adoption of technologically advanced diagnostic equipment.High Incidence Rate of Cardiovascular Disorders to Drive MarketAccording to the statistics reported by WHO, cardiovascular diseases are the number one cause of death, accounting for nearly 17.9 million deaths globally every year.

The primary causes of high incidence of cardiovascular diseases include diabetes, smoking, hyperlipidemia, hypertension, obesity, poor nutrition, and lack of physical activity.

The IVUS consoles segment dominated the market in 2020, owing to rise in the demand for intravascular ultrasound consoles assisted cardiovascular surgeries.Need of Intravascular Ultrasound (IVUS) Devices in Coronary InterventionIn terms of application, the global intravascular ultrasound (IVUS)   has been classified into coronary diagnosis, coronary intervention, coronary research, and non-coronary/peripheral applications.

collect
1
Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report titled, ‘HIV/AIDS Immunoassay Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global HIV/AIDS immunoassay diagnostics market was valued at ~US$ 550 Mn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=74619OverviewHuman immunodeficiency virus (HIV) belongs to the retrovirus family.

HIV is transmitted through unprotected sex with an infected person, transfusion of HIV infected blood, and sharing needles contaminated with HIV infected blood.Rise in prevalence of HIV across the globe, HIV infections among young population, blood donations, awareness about HIV diagnosis across the globe, and favorable initiatives by governments for HIV/AIDS diagnosis and prevention are key factors that are anticipated to drive the global HIV/AIDS immunoassay diagnostics market during the forecast periodNorth America held a major share of the global HIV/AIDS immunoassay diagnostics market in 2018.

It is primarily driven by factors such as presence of key market players, highly structured health care industry, and key developments by market players such as product launch approvals, key mergers, and acquisitions.The HIV/AIDS immunoassay diagnostics market in Asia Pacific is expected to expand at a high CAGR of ~7% from 2019to Increase in the number of people with sexually transmitted diseases, rise in incidence of HIV infection among young adults, product approvals, and rise in awareness about HIV/AIDS diseases are factors anticipated to fuel the growth of the HIV/AIDS immunoassay diagnostics market in the region.TOC of Report – https://www.transparencymarketresearch.com/report-toc/74619Increase in Prevalence of HIV Infections across the Globe to Drive MarketHIV is basically transmitted through unprotected sex with an infected person, transfusion of HIV infected blood, and sharing needles contaminated with HIV infected blood.

Rise in the number of patients with HIV contamination at an alarming rate in several countries is a major factor likely to drive the revenue of a large number of diagnostic labs and clinics in the near future.According to the WHO, HIV continues to be a major global public health issue.

Based on UNAIDS report 2018, 39.6 million adults and children were living with HIV and approximately 940,000 individuals died from HIV globally.Approximately 7 millionpeople were newly infected with HIV globally, in 2018Majority of the affected population lives in lower and middle-income countries.

Moreover, Eastern Europe witnessed a 29%increase in new HIV infections annually between 2010 and 2018.Request Customization on HIV/AIDS Immunoassay Diagnostics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=74619Kits & Reagents Dominated HIV/AIDS Immunoassay Diagnostics MarketIn terms of product, the global HIV/AIDS immunoassay diagnostics market can be classified into analyzers and kits & reagentsThe kits & reagents segment dominated the global HIV/AIDS immunoassay diagnostics market in 2018 and the trend is projected to continue during the forecast period.

collect
1
Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report on the corneal topographers market for the forecast period of 2019–2027.According to the report, the global corneal topographers marketwas valued at ~US$ 920 Mn in 2018, and is projected to expand at a CAGR of 5% from 2019 to 2027.

The global corneal topographers market is driven by an increase in the awareness and acceptance of corneal topographers due to the advent of new technologies, and increase in incidence of ophthalmic and ocular conditions.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=73446The global corneal topographers market has been segmented based on product, application, end user, and region.In terms of product, the global corneal topographers market has been classified into optical coherence tomography (OCT), placido, scheimpflug, ray tracing, LED triangulation, and others.Based on application, the global corneal topographers market has been categorized into corneal ectatic disorder diagnosis, contact lens fitting, cataract surgery evaluation, post-penetrating keratoplasty, evaluation of post-refractive surgery, keratoconus, and others.In terms of end user, the global corneal topographers market has been divided into hospitals, ophthalmology clinics, ambulatory surgical centers, and others.Request COVID Analysis on Corneal Topographers Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=73446Optical Coherence Tomography (OCT) to Dominate MarketOptical coherence tomography (OCT) is a novel optical imaging technological platform that achieves high resolution, cross-sectional tomographic imaging of the posterior part of the eyes.

OCT is based on optical interference, and the system comprises a reference arm and a sample arm.

This sample light is then mixed with the light reflected from the reference arm of the system.These features have increased the adoption of OCT technology in a range of research and clinical applications, which, in turn, boosts the growth of the segment in the global corneal topographers market.To know the scope of our report Get a Sample on Corneal Topographers Market Contact Lens Fitting to Lead MarketContact lenses are medical devices worn directly on the cornea of the eyes, and are used to modify refractive errors by adding or subtracting the concentrating power of the cornea and lens.

Scratching of the cornea, redness of eyes, high possibility of infections, and contact lens intolerance are some of the risk factors associated with contact lenses.Increase in the usage of optical coherence tomography and corneal topographers in contact lens fitting is expected to boost the growth of the segment in the global corneal topographers market.Request Customization on Corneal Topographers Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=73446Aging Population and Rise in Number of Vision Correction Procedures to Propel MarketThe global geriatric population is increasing at a steady rate, owing to factors such as rise in life expectancy because of improved access to better healthcare facilities.According to the World Health Organization (WHO) estimates, the global geriatric population will reach around 2 billion(22% of the overall population) by 2050, from around 962 million in 2017Rise in the incidence of age-related eye disorders has increased the number of vision correction procedures such as LASIK and cataract surgeries.Hence, aging population and rise in number of vision correction procedures are projected to fuel the growth of the global corneal topographers market.Increase in Risk of Cataract among Diabetic Population to Drive MarketThe prevalence of diabetes is increasing at a rapid pace across the globe, with diabetes type 2 being the primary reason for this alarming rise.Increase in the geriatric population and rise in the number of diabetic patients have led to high incidence of age-related cataract and other eye disorders such as macular degeneration and glaucoma.According to the International Diabetes Federation (IDF), an estimated 337 millionpeople across the world were suffering from diabetes in 2016; Asia Pacific accounted for the largest number of diabetic patients.According to the American Journal of Ophthalmology and numerous other studies, diabetes can affect most ocular tissues, and is one the major reasons for age-related cataract.Hence, increase in the diabetic population and high risk of cataract in this population are expected to drive the global corneal topographers market during the forecast period.Buy Corneal Topographers Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=73446=SNorth America a Prominent Corneal Topographers MarketNorth America held the largest share of 0%of the global corneal topographers market in 2018.

This is attributed to continuous product modifications followed by technological advances in corneal topography and optical coherence tomography systems.Additionally, the increased participation of manufacturers in the development of robust and effective devices incorporated with latest technologies boosts the growth and acceptance of corneal topographers and optical coherence tomography devices across the globe.Increase in the geriatric population provides significant opportunities for the development of efficient devices and surgery methodologies.

collect
1
Devanand Patil 2021-11-12
img

According to the report, the global plantar fasciitis treatment market was valued at ~ US$ 695 Mn in 2018, and is projected to expand at a CAGR of 4.3% from 2019 to 2027.

Rise in the patient population and surge in the adoption of technologically-advanced products are the major factors anticipated to drive the global plantar fasciitis treatment market from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=47658Increase in Burden of Patient Population to Drive Plantar Fasciitis Treatment MarketPlantar fasciitis is one of the most common foot pain conditions.

Plantar fasciitis is primarily caused due to repetitive strain on the ankle, leading to progressive wear and tear and degeneration of plantar fascia, a thick connective tissue covering the lower side of the foot.The obese and geriatric populations are more prone to plantar fasciitis.

It leads to sharp pain and other complications, in which, plantar fascia, a tissue connecting the heel and the toe bones becomes less flexible and more constrained.Rise in the number of individuals living sedentary lifestyles coupled with changes in eating habits leads to an increase in obesity, which puts pressure on the joints and ankles, and can result in plantar fasciitis.Increase in the percentage of geriatric and obese populations is likely to propel the number of patients suffering from plantar fasciitis.Moreover, prolonged standing, weight bearing, ill-fitted shoes, incorrect walking posture, and sudden rise in sports activities can trigger micro-tears in the plantar fascia, and lead to plantar fasciitis.This multi-factorial etiology of the disease is anticipated to drive the global plantar fasciitis treatment market during the forecast period.Request COVID Analysis on Plantar Fasciitis Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=47658Orthotics Treatment Type to Gain Market Share and offer Lucrative OpportunitiesThe report offers detailed segmentation of the global plantar fasciitis treatment market based on type, end user, and region.

Increase in the penetration of leading players in the region is expected to boost the plantar fasciitis treatment market in the region during the forecast period.The plantar fasciitis treatment market in Asia Pacific is primarily driven by the surge in investments in healthcare infrastructure, rise in disposable income of people, economic growth, large population base with chronic diseases & other foot pain conditions, and expansion in the distribution networks of leading players in the region to establish themselves in lucrative plantar fasciitis treatmentBuy Continuous Plantar Fasciitis Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=47658=SDr.

These include Hanger, Inc., Bayer Group (Dr. Scholl's), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.Hanger, Inc. is a U.S.-based manufacturer and distributor of orthotic and prosthetic devices, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings.

collect
1
Devanand Patil 2021-11-11
img

Cleanroom Consumables Market: IntroductionThe global cleanroom consumables market was valued over US$ 16.4 Bn in 2020 and is projected to expand at a CAGR of 0.4% from 2021 to 2031.

Surge in the number of patients with infectious diseases such as coronavirus; advances in cleanroom laboratory setup such as modular labs and mobile laboratories; and advent of nanotechnology are anticipated to drive the global cleanroom consumables market from 2021 to 2031.

Additionally, the region as a whole adheres to stringent regulatory norms, contributing to the rise in the need of advanced and compliant devices and processes in cleanroom consumables.

Significant growth of the biotechnology & pharmaceutical industry is likely to boost the market in the region.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=3995The market in the North America is driven by the U.S.

Moreover, recent rise in cases of coronavirus in the country, which has been declared as the new global epicenter, has fueled the demand for cleanroom consumables.Rise in Health Concerns to Propel MarketCleanroom consumables, such as facemasks, coveralls, and shoe and boot covers help to create a barrier between the wearer and contaminants in the surrounding.

Rise in transmission of infectious diseases among people owing to various reasons, including increase in number of microorganisms causing respiratory diseases, and surge in the number of mutants of a single species contribute to health concerns among the people.

collect
1
Devanand Patil 2021-11-12
img

According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11714Varicose vein is one of the common diseases caused due to damage to the vein valves.

Endovenous ablation is a less-invasive treatment option for varicose veins.In terms of treatment type, the supportive treatments segment accounted for a major share of the global varicose vein treatment market in 2018.

Moreover, increase in awareness about ablation devices is expected to fuel the growth of the segment.

Based on end user, the hospitals & ambulatory surgical centers segment accounted for a major share of the market, due to the availability of services and rise in the rate of hospitalization.

Moreover, the preference for ambulatory surgical centers due to short hospital stays is likely fuel the growth of the segment.Request COVID Analysis on Varicose Vein Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=11714Global Varicose Vein Treatment Market: Prominent RegionsNorth America held a major share of the global varicose vein treatment market in 2018.

According to the American Heart Association, Inc., the prevalence of reticular vein and spider telangiectasias is higher in women in the U.S. Europe held the second-largest share of the global varicose vein treatment market in 2018.

collect
1
Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report on the global hemostasis valves market for the forecast period of 2019–2027.

In turn, this is expected to boost the hemostasis valves market.According to the 2016Heart Disease and Stroke Statistics update of the American Heart Association (AHA), more than 15 million people over 20 years of age in the U.S. suffer from coronary heart disease (CHD).The incidence of coronary artery disease (CAD) has increased significantly in low-income and middle-income countries such as India.

Request COVID Analysis on Hemostasis Valves Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=58530 Market in Asia Pacific to Expand at Rapid PaceNorth America held a major share of the global hemostasis valves market in terms of revenue in 2018.

Advanced surgical techniques and the presence of leading players are estimated to boost the market in the near future.

High disposable income and well-developed healthcare infrastructure are also augmenting the market in North America.Europe is anticipated to be the second-largest market in terms of share and revenue during the forecast period.

These include Boston Scientific Corporation Terumo Corporation, Merit Medical Systems, Inc., Freudenberg Medical, and ARGON MEDICAL.Boston Scientific Corporation is one of the leading providers of hemostasis valves in the U.S.

collect
1
Devanand Patil 2021-11-12
img

The demand within the global non-invasive ventilators market is set to increase at a sound pace in the times to follow.

There is little contention about the unprecedented use of ventilators across all major healthcare facilities.

In addition to this, majority of medical practitioners focus on developing a robust infrastructure that can aid the operations of the healthcare sector.

In this scenario, the total volume of revenues within the global non-invasive ventilators market shall grow at a sturdy pace.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=54720 In this review, Transparency Market Research (TMR) debunks several anomalies related to the growth of the global non-invasive ventilators market.

It is estimated that the total worth of the global non-invasive ventilators market would touch US$ 2.7 Bn by the end of 2027.

Moreover, the national development index of countries largely depends on the quality of healthcare equipment and devices available across various centers.

collect
0
Devanand Patil 2021-11-11
img

Newborn Screening Market: IntroductionAccording to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031.

Newborn screening helps in the early detection of serious genetic diseases, which may result in disability or death if not treated at the initial stage.

Different types of instrument and assay kits are used in the diagnosis of newborn disorders.

Hearing screening devices and pulse oximeter are regularly used in the diagnosis of newborn disorders.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=4581The growth of the global newborn screening market can be ascribed to the rise in prevalence of critical congenital heart defects and government support.

The U.S. has a national program of newborn screening tests to check for several different disorders that can be treated, if found very early in life.North America dominated the global newborn screening market in 2019.

According to the Indian Academy of Pediatrics, more than 200,000 children are estimated to be born with CHD in India every year.

collect
0
Devanand Patil 2022-07-18
With the advent of contingency plans across countries and financial institutions proposing relief plans, the automotive industry and in turn, the automotive axle market can make a strong comeback the COVID-19 impact. The types of automotive axle in the market include front axle as well as rear axle. Both these countries boast of an enormous automotive industry, which works in favor of the axle industry. Significant CompetitorsSignificant competitors in the automotive axle industry include Meritor Inc. It is said that 60 percent of the power distribution could go to the front axleAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report titled, ‘HIV/AIDS Immunoassay Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global HIV/AIDS immunoassay diagnostics market was valued at ~US$ 550 Mn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=74619OverviewHuman immunodeficiency virus (HIV) belongs to the retrovirus family.

HIV is transmitted through unprotected sex with an infected person, transfusion of HIV infected blood, and sharing needles contaminated with HIV infected blood.Rise in prevalence of HIV across the globe, HIV infections among young population, blood donations, awareness about HIV diagnosis across the globe, and favorable initiatives by governments for HIV/AIDS diagnosis and prevention are key factors that are anticipated to drive the global HIV/AIDS immunoassay diagnostics market during the forecast periodNorth America held a major share of the global HIV/AIDS immunoassay diagnostics market in 2018.

It is primarily driven by factors such as presence of key market players, highly structured health care industry, and key developments by market players such as product launch approvals, key mergers, and acquisitions.The HIV/AIDS immunoassay diagnostics market in Asia Pacific is expected to expand at a high CAGR of ~7% from 2019to Increase in the number of people with sexually transmitted diseases, rise in incidence of HIV infection among young adults, product approvals, and rise in awareness about HIV/AIDS diseases are factors anticipated to fuel the growth of the HIV/AIDS immunoassay diagnostics market in the region.TOC of Report – https://www.transparencymarketresearch.com/report-toc/74619Increase in Prevalence of HIV Infections across the Globe to Drive MarketHIV is basically transmitted through unprotected sex with an infected person, transfusion of HIV infected blood, and sharing needles contaminated with HIV infected blood.

Rise in the number of patients with HIV contamination at an alarming rate in several countries is a major factor likely to drive the revenue of a large number of diagnostic labs and clinics in the near future.According to the WHO, HIV continues to be a major global public health issue.

Based on UNAIDS report 2018, 39.6 million adults and children were living with HIV and approximately 940,000 individuals died from HIV globally.Approximately 7 millionpeople were newly infected with HIV globally, in 2018Majority of the affected population lives in lower and middle-income countries.

Moreover, Eastern Europe witnessed a 29%increase in new HIV infections annually between 2010 and 2018.Request Customization on HIV/AIDS Immunoassay Diagnostics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=74619Kits & Reagents Dominated HIV/AIDS Immunoassay Diagnostics MarketIn terms of product, the global HIV/AIDS immunoassay diagnostics market can be classified into analyzers and kits & reagentsThe kits & reagents segment dominated the global HIV/AIDS immunoassay diagnostics market in 2018 and the trend is projected to continue during the forecast period.

Devanand Patil 2021-11-12
img

According to the report, the global photodynamic therapy market was valued at ~US$ 3 Bn in 2018, and is projected to expand at a CAGR of ~17% from 2019 to 2027.Read Report Overview - https://www.transparencymarketresearch.com/photodynamic-therapy-market.html Global Photodynamic Therapy Market: Key InsightsPhotodynamic therapy is a part of treatment that uses drugs and devices for the treatment of different chronic diseases such as cancer and malignant musculoskeletal tumors.Increase in the prevalence as well as incidence of cancer and skin diseases, growth in the number of surgeries, and approval of new biologics are major factors anticipated to drive the global photodynamic therapy market during the forecast period.According to the National Cancer Institute of the U.S., around 1,735,350 new cancer cases were diagnosed in the U.S. in 2018.

The USPTO granted a patent titled as ‘Metal-based Thiophene Photodynamic Compounds and their Use.’The photodynamic therapy market in Asia Pacific is expected to expand at a high CAGR of ~18%from 2019 to 2027, due to surge in the number of patients with psoriasis and acne, and rise in the demand for innovative cosmetic therapies in India, China, and South Korea.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=69615Rise in Prevalence of Skin Diseases to Drive Global Photodynamic Therapy MarketRise in the prevalence of skin diseases, worldwide, is projected to drive the global photodynamic therapy market during the forecast period.Acne is considered one of the most common skin conditions in the U.S., which affects over 50 millionpeople in the country every year.

Its prevalence is known to be higher among women, affecting over 15% of the total population of adult women.Psoriasis is known to affect over5 million people in the U.S. every year, with a higher rate of prevalence among people aged between 45 and 64 years.

This significant rise in the prevalence of skin diseases and the economic burden of these diseases generate high demand for photodynamic therapy, which is a cost-effective option.Request COVID Analysis on Photodynamic Therapy Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=69615Photosensitizers Drugs Dominate Global Photodynamic Therapy MarketIncrease in the number of clinical trials for the development of new photosensitizers, rise in the number of market players strengthening their research and development activities, and increase in expenditure on new drug development are various factors expected to drive the drugs segment during the forecast period.In September 2018, Health Canada approved the clinical trial application (CTA) filed by Theralase Technologies Inc., allowing clinical study evaluation of Theralase’s lead anti-cancer drug, i.e.

TLD-1433.Cancer the Most Prominent Application in Photodynamic Therapy MarketIn terms of application, the global photodynamic therapy market has been segmented into cancer, actinic keratosis (AK), psoriasis, acne, and others.

In October 2019, Theralase Technologies Inc. was granted a patent in Europe for its anti-cancer light-activated photodynamic compounds (PDCs).Request Customization on Photodynamic Therapy Market Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=69615Hospitals a Promising End User of Global Photodynamic Therapy MarketIn terms of end user, the global photodynamic therapy market has been categorized into hospitals, cosmetics & dermatology clinics, cancer treatment centers, and others.The cosmetics & dermatology clinics segment is likely to gain significant market share by 2027.

Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report on the corneal topographers market for the forecast period of 2019–2027.According to the report, the global corneal topographers marketwas valued at ~US$ 920 Mn in 2018, and is projected to expand at a CAGR of 5% from 2019 to 2027.

The global corneal topographers market is driven by an increase in the awareness and acceptance of corneal topographers due to the advent of new technologies, and increase in incidence of ophthalmic and ocular conditions.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=73446The global corneal topographers market has been segmented based on product, application, end user, and region.In terms of product, the global corneal topographers market has been classified into optical coherence tomography (OCT), placido, scheimpflug, ray tracing, LED triangulation, and others.Based on application, the global corneal topographers market has been categorized into corneal ectatic disorder diagnosis, contact lens fitting, cataract surgery evaluation, post-penetrating keratoplasty, evaluation of post-refractive surgery, keratoconus, and others.In terms of end user, the global corneal topographers market has been divided into hospitals, ophthalmology clinics, ambulatory surgical centers, and others.Request COVID Analysis on Corneal Topographers Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=73446Optical Coherence Tomography (OCT) to Dominate MarketOptical coherence tomography (OCT) is a novel optical imaging technological platform that achieves high resolution, cross-sectional tomographic imaging of the posterior part of the eyes.

OCT is based on optical interference, and the system comprises a reference arm and a sample arm.

This sample light is then mixed with the light reflected from the reference arm of the system.These features have increased the adoption of OCT technology in a range of research and clinical applications, which, in turn, boosts the growth of the segment in the global corneal topographers market.To know the scope of our report Get a Sample on Corneal Topographers Market Contact Lens Fitting to Lead MarketContact lenses are medical devices worn directly on the cornea of the eyes, and are used to modify refractive errors by adding or subtracting the concentrating power of the cornea and lens.

Scratching of the cornea, redness of eyes, high possibility of infections, and contact lens intolerance are some of the risk factors associated with contact lenses.Increase in the usage of optical coherence tomography and corneal topographers in contact lens fitting is expected to boost the growth of the segment in the global corneal topographers market.Request Customization on Corneal Topographers Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=73446Aging Population and Rise in Number of Vision Correction Procedures to Propel MarketThe global geriatric population is increasing at a steady rate, owing to factors such as rise in life expectancy because of improved access to better healthcare facilities.According to the World Health Organization (WHO) estimates, the global geriatric population will reach around 2 billion(22% of the overall population) by 2050, from around 962 million in 2017Rise in the incidence of age-related eye disorders has increased the number of vision correction procedures such as LASIK and cataract surgeries.Hence, aging population and rise in number of vision correction procedures are projected to fuel the growth of the global corneal topographers market.Increase in Risk of Cataract among Diabetic Population to Drive MarketThe prevalence of diabetes is increasing at a rapid pace across the globe, with diabetes type 2 being the primary reason for this alarming rise.Increase in the geriatric population and rise in the number of diabetic patients have led to high incidence of age-related cataract and other eye disorders such as macular degeneration and glaucoma.According to the International Diabetes Federation (IDF), an estimated 337 millionpeople across the world were suffering from diabetes in 2016; Asia Pacific accounted for the largest number of diabetic patients.According to the American Journal of Ophthalmology and numerous other studies, diabetes can affect most ocular tissues, and is one the major reasons for age-related cataract.Hence, increase in the diabetic population and high risk of cataract in this population are expected to drive the global corneal topographers market during the forecast period.Buy Corneal Topographers Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=73446=SNorth America a Prominent Corneal Topographers MarketNorth America held the largest share of 0%of the global corneal topographers market in 2018.

This is attributed to continuous product modifications followed by technological advances in corneal topography and optical coherence tomography systems.Additionally, the increased participation of manufacturers in the development of robust and effective devices incorporated with latest technologies boosts the growth and acceptance of corneal topographers and optical coherence tomography devices across the globe.Increase in the geriatric population provides significant opportunities for the development of efficient devices and surgery methodologies.

Devanand Patil 2021-11-12
img

Thoracic Drainage Devices Market: Key FindingsTransparency Market Research has published a new report on the global thoracic drainage devices market.

The segment is likely to continue to dominate the market during the forecast period, owing to an increase in the adoption of thoracic drainage systems in hospitals due to a rise in the demand for surgical procedures.

A thoracic drainage system also offers advanced technological benefits such as portability and new generation of smaller user-friendly digital systems and additional safety features.In terms of application, the thoracic surgery & pulmonology segment is anticipated to account for a major share of the global thoracic drainage devices market.

Thoracic and pulmonological disorders are quite common, and the prevalence of these disorders is increasing.

It is caused due to collection of air in the chest cavity, which gets resolved on its own; however, most often, it requires hospital admission and urgent medical care.Rise in product recalls owing to improper packaging and malfunction, shortage of physicians, and challenges in maintaining chest tube patency are expected to hamper the growth of the global thoracic drainage devices market during the forecast period.Request Customization on Thoracic Drainage Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=40529Global Thoracic Drainage Devices Market: Prominent RegionsNorth America held a major share of the global thoracic drainage devices market in 2018.

Additionally, R activities being carried out to introduce new thoracic drainage devices with improved design and technology by a large number of market players in North America are driving the thoracic drainage devices market in the region.Europe held a significant market share in 2018, after North America.

Devanand Patil 2021-11-12
img

According to the report, the global plantar fasciitis treatment market was valued at ~ US$ 695 Mn in 2018, and is projected to expand at a CAGR of 4.3% from 2019 to 2027.

Rise in the patient population and surge in the adoption of technologically-advanced products are the major factors anticipated to drive the global plantar fasciitis treatment market from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=47658Increase in Burden of Patient Population to Drive Plantar Fasciitis Treatment MarketPlantar fasciitis is one of the most common foot pain conditions.

Plantar fasciitis is primarily caused due to repetitive strain on the ankle, leading to progressive wear and tear and degeneration of plantar fascia, a thick connective tissue covering the lower side of the foot.The obese and geriatric populations are more prone to plantar fasciitis.

It leads to sharp pain and other complications, in which, plantar fascia, a tissue connecting the heel and the toe bones becomes less flexible and more constrained.Rise in the number of individuals living sedentary lifestyles coupled with changes in eating habits leads to an increase in obesity, which puts pressure on the joints and ankles, and can result in plantar fasciitis.Increase in the percentage of geriatric and obese populations is likely to propel the number of patients suffering from plantar fasciitis.Moreover, prolonged standing, weight bearing, ill-fitted shoes, incorrect walking posture, and sudden rise in sports activities can trigger micro-tears in the plantar fascia, and lead to plantar fasciitis.This multi-factorial etiology of the disease is anticipated to drive the global plantar fasciitis treatment market during the forecast period.Request COVID Analysis on Plantar Fasciitis Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=47658Orthotics Treatment Type to Gain Market Share and offer Lucrative OpportunitiesThe report offers detailed segmentation of the global plantar fasciitis treatment market based on type, end user, and region.

Increase in the penetration of leading players in the region is expected to boost the plantar fasciitis treatment market in the region during the forecast period.The plantar fasciitis treatment market in Asia Pacific is primarily driven by the surge in investments in healthcare infrastructure, rise in disposable income of people, economic growth, large population base with chronic diseases & other foot pain conditions, and expansion in the distribution networks of leading players in the region to establish themselves in lucrative plantar fasciitis treatmentBuy Continuous Plantar Fasciitis Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=47658=SDr.

These include Hanger, Inc., Bayer Group (Dr. Scholl's), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.Hanger, Inc. is a U.S.-based manufacturer and distributor of orthotic and prosthetic devices, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings.

Devanand Patil 2021-11-11
img

Sepsis Treatment Market: IntroductionAccording to the report, the global sepsis treatment market was valued over US$ 600 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

Sepsis is a life threatening disease caused when a chemical develops in the immune system and is released into the bloodstream.

According to the Centers for Disease Control and Prevention, over 1.5 million cases of sepsis are reported globally each year.

Increase in the population above 65 years of age asserts the need of safe and effective therapeutics for sepsis treatment.

Leading pharmaceutical companies focus on addressing these unmet medical needs through new product development.

According to research, increase in geriatric population leads to rise in prevalence of atrial fibrillation and other cardiac diseases.

Devanand Patil 2021-11-11
img

Cleanroom Consumables Market: IntroductionThe global cleanroom consumables market was valued over US$ 16.4 Bn in 2020 and is projected to expand at a CAGR of 0.4% from 2021 to 2031.

Surge in the number of patients with infectious diseases such as coronavirus; advances in cleanroom laboratory setup such as modular labs and mobile laboratories; and advent of nanotechnology are anticipated to drive the global cleanroom consumables market from 2021 to 2031.

Additionally, the region as a whole adheres to stringent regulatory norms, contributing to the rise in the need of advanced and compliant devices and processes in cleanroom consumables.

Significant growth of the biotechnology & pharmaceutical industry is likely to boost the market in the region.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=3995The market in the North America is driven by the U.S.

Moreover, recent rise in cases of coronavirus in the country, which has been declared as the new global epicenter, has fueled the demand for cleanroom consumables.Rise in Health Concerns to Propel MarketCleanroom consumables, such as facemasks, coveralls, and shoe and boot covers help to create a barrier between the wearer and contaminants in the surrounding.

Rise in transmission of infectious diseases among people owing to various reasons, including increase in number of microorganisms causing respiratory diseases, and surge in the number of mutants of a single species contribute to health concerns among the people.

Devanand Patil 2021-11-12
img

Respiratory Monitoring Devices Market: IntroductionRespiratory monitoring plays a significant role in the management of patients with respiratory diseases, such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), and asthma, among other diseases.

There are a number of technologically advanced respiratory monitoring devicesavailable in the market for personal use, intensive care, and inpatient settings.Increase in the prevalence of respiratory diseases, such as asthma, cystic fibrosis, and COPD, and rising geriatric population are major factors that are anticipated to drive the global respiratory monitoring devices market during the forecast periodRequest Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1415According to the World Health Organization, the global geriatric population was approximately 524 millionin- and is anticipated to reach 5 billion by 2050.

Moreover, world population is aging at a rapid pace, especially people in developed nations such as the U.S., Germany, and Japan.North America held a leading share of the global respiratory monitoring devices market in 2018due to the increase in the number of asthma cases and favorable medical schemes and reimbursement policiesAccording to the Behavioral Risk Factor Surveillance System (BRFSS) survey, in 2017, nearly 9 millionadults in the U.S. had asthma and around 16.3 million adults were diagnosed with COPD.

The survey also stated that nearly 33.2 million adults had chronic lung diseases.The respiratory monitoring devices market in Asia Pacific is expected to expand at a high CAGR of ~7%from 2019 to 2027 due to the growing healthcare expenditure, increasing prevalence of respiratory disorders, and improving healthcare infrastructureRequest COVID Analysis on Respiratory Monitoring Devices Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1415Rise in Prevalence Rate of Respiratory Diseases to Drive Respiratory Monitoring Devices MarketRise in prevalence rate of respiratory diseases worldwide is projected to drive the global respiratory monitoring devices market during the forecast periodApproximately 50% of Latin American countries reported that around 15%of the population suffered from childhood asthma, revealed by Forno and Colleagues in the journal Thorax published in December 2016According to the WHO, in 2015, globally, there were 100 million people affected with chronic respiratory diseases with sleep apnea being the most common problemRequest Customization on Respiratory Monitoring Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=1415Increase in Use of Pulse Oximeters in Clinics and LaboratoriesIn terms of product, the global respiratory monitoring devices market has been segmented into pulse oximeters, capnographs, spirometers, polysomnographs (PSG), peak flow meters, gas analyzers, and others.

The pulse oximeter segment accounted for a major market share in 2018.Technological advancements related to respiratory monitoring equipment and high utilization of pulse oximeters in clinics and laboratories are various factors that are likely to drive the pulse oximeters segment during the forecast periodRise in demand for non-invasive respiratory monitors is expected to accelerate the growth of the global respiratory monitoring devices marketIn November 2015, Montefiore Medical Center developed a non-invasive pulseless oximeter, which measures arterial oxygenation in patients with weak pulseHospitals to be Major End User of Respiratory Monitoring DevicesBased on end user, the global respiratory monitoring devices market has been categorized into home care, hospitals, ambulatory surgical centers, and specialty clinicsThe home care segment is likely to gain significant market share by Growth of this segment can be attributed to the increase in the adoption of respiratory monitoring devices for home use, rise in the number of market players launching portable devices, and growing demand for home use spirometers and peak flow meters.Buy Respiratory Monitoring Devices Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=1415=SNorth America to Lead Respiratory Monitoring Devices MarketIn terms of region, the global respiratory monitoring devices market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

North America is projected to account for a leading share of the global respiratory monitoring devices market during the forecast period, owing to the increase in the number of market players receiving FDA approval, new product launches, and significant growth of diagnostic medical devices market.In January 2019,Masimo received the FDA approval for MightSat Rx finger pulse oximeter that can be used at home, thereby expanding its share of the respiratory monitoring devices marketIn June 2015,Cohero Health received the FDA approval for mobile connected spirometer, a Bluetooth-connected device the measures critical lung functionGrowth Strategies of Key PlayersKey players operating in the global respiratory monitoring devices market are Medtronic, Philips Healthcare (Koninklijke Philips N.V.), Smiths Medical (part of Smiths Group plc), Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Welch Allyn, Inc. (Hill-Rom Holdings, Inc.), Masimo, MGC Diagnostics Corporation, Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture), Nihon Kohden Corporation, and Novelda ASLaunch of products for home use and increase in research and development activities by prominent players are major strategies adopted by companies operating in the respiratory monitoring devices marketGlobal Respiratory Monitoring Devices Market: SegmentationRespiratory Monitoring Devices Market, by ProductPulse OximetersCapnographsSpirometersPolysomnographs (PSG)Peak Flow MetersGas AnalyzersOthersRespiratory Monitoring Devices Market, by End UserHome careHospitalsAmbulatory Surgical CentersSpecialty Clinics Respiratory Monitoring Devices Market, by RegionNorth AmericaS.CanadaEuropeGermanyK.FranceSpainItalyRest of EuropeAsia PacificJapanChinaIndiaAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC CountriesSouth AfricaRest of Middle East & AfricaAbout UsTransparency Market Research is a global market intelligence company providing global business information reports and services.

Devanand Patil 2021-11-12
img

According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11714Varicose vein is one of the common diseases caused due to damage to the vein valves.

Endovenous ablation is a less-invasive treatment option for varicose veins.In terms of treatment type, the supportive treatments segment accounted for a major share of the global varicose vein treatment market in 2018.

Moreover, increase in awareness about ablation devices is expected to fuel the growth of the segment.

Based on end user, the hospitals & ambulatory surgical centers segment accounted for a major share of the market, due to the availability of services and rise in the rate of hospitalization.

Moreover, the preference for ambulatory surgical centers due to short hospital stays is likely fuel the growth of the segment.Request COVID Analysis on Varicose Vein Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=11714Global Varicose Vein Treatment Market: Prominent RegionsNorth America held a major share of the global varicose vein treatment market in 2018.

According to the American Heart Association, Inc., the prevalence of reticular vein and spider telangiectasias is higher in women in the U.S. Europe held the second-largest share of the global varicose vein treatment market in 2018.

Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report on the systemic lupus erythematosus treatment market for the forecast period of 2019–2027.

According to the report, the global systemic lupus erythematosus treatment market was valued at ~US$ 1.7 Bn in 2018, and is projected to expand at a CAGR of ~7% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=73932Systemic Lupus Erythematosus Treatment Market: OverviewGrowth of the global systemic lupus erythematosus treatment market can be attributed to rise in the incidence of systemic lupus erythematosus, and promising drug pipeline and approvals.North America dominated the global systemic lupus erythematosus treatment market in 2018, and the trend is anticipated to continue during the forecast period.

).The immunosuppressive drugs segment dominated the global systemic lupus erythematosus treatment market in 2018, and the trend is likely to continue during the forecast period.Immunosuppressive drugs such as azathioprine, cyclophosphamide, and methotrexate help control inflammation and the overactive immune system in the treatment of SLE.

This, in turn, is projected to drive the segment during the forecast period.Furthermore, major market players are focusing on the launching of new products in the tablet and capsule form.

Moreover, drug degradation is less as compared to the oral route of administration.Retail Pharmacies Accounted for Major Share of MarketBased on distribution channel, the global systemic lupus erythematosus treatment market has been segmented into hospital pharmacies, retail pharmacies, and online sales.The retail pharmacies segment dominated the global systemic lupus erythematosus treatment market in terms of revenue in 2018,and the trend is projected to continue during the forecast period.

Increase in the number of retail pharmacy stores across the globe, availability of new products in retail stores, and availability of most of the drugs, such as NSAIDS, antimalarial drugs, and corticosteroids, as OTC drugs in retail stores, are likely to propel this segment during the forecast period.Hospital pharmacies is expected to be the second-most lucrative segment of the global systemic lupus erythematosus treatment market during the forecast period.

Devanand Patil 2021-11-12
img

Transparency Market Research (TMR) has published a new report on the global hemostasis valves market for the forecast period of 2019–2027.

In turn, this is expected to boost the hemostasis valves market.According to the 2016Heart Disease and Stroke Statistics update of the American Heart Association (AHA), more than 15 million people over 20 years of age in the U.S. suffer from coronary heart disease (CHD).The incidence of coronary artery disease (CAD) has increased significantly in low-income and middle-income countries such as India.

Request COVID Analysis on Hemostasis Valves Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=58530 Market in Asia Pacific to Expand at Rapid PaceNorth America held a major share of the global hemostasis valves market in terms of revenue in 2018.

Advanced surgical techniques and the presence of leading players are estimated to boost the market in the near future.

High disposable income and well-developed healthcare infrastructure are also augmenting the market in North America.Europe is anticipated to be the second-largest market in terms of share and revenue during the forecast period.

These include Boston Scientific Corporation Terumo Corporation, Merit Medical Systems, Inc., Freudenberg Medical, and ARGON MEDICAL.Boston Scientific Corporation is one of the leading providers of hemostasis valves in the U.S.

Devanand Patil 2021-11-12
img

Due to rising prostate issues including growth of major issues like prostate cancer, the market will likely reach US 12 billion in valuation by 2027.

The new cases of prostate ailments and minimally surgical procedures as well as potency and efficacy of the new drugs will drive growth of the benign prostatic hyperplasia treatment market.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=72273The rise of the disease among middle-aged men is a newly discovered and growing cause of concern in the healthcare sector.

The surrounding campaigns like national prostate health month, and rising awareness of the disease in the region are expected to create new opportunities for players in the benign prostatic hyperplasia treatment market.Request COVID Analysis on Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=72273Rising Cases Presents a Major Challenge for the Healthcare SectorCurrently, BPH presents the most common form of benign among various tumor cases.

It is estimated that there are over 8 million American men who are suffering from the condition and 22 million patients suffer its mild symptoms.

Moreover, the growth of the tumor can make it difficult to operate on other serious ailments like prostate cancer among people above 90, whose risks is as high as 60%.Request Customization on Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Report –  https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=72273Rising Elderly Population to Drive Robust Growth GloballyRising geriatric population globally is expected to create significant opportunities for expansion for existing players in the market.

The population is also expected to rise at the fastest rate in the US, Japan, UK, China, Brazil, among others.

Devanand Patil 2021-11-12
img

The demand within the global non-invasive ventilators market is set to increase at a sound pace in the times to follow.

There is little contention about the unprecedented use of ventilators across all major healthcare facilities.

In addition to this, majority of medical practitioners focus on developing a robust infrastructure that can aid the operations of the healthcare sector.

In this scenario, the total volume of revenues within the global non-invasive ventilators market shall grow at a sturdy pace.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=54720 In this review, Transparency Market Research (TMR) debunks several anomalies related to the growth of the global non-invasive ventilators market.

It is estimated that the total worth of the global non-invasive ventilators market would touch US$ 2.7 Bn by the end of 2027.

Moreover, the national development index of countries largely depends on the quality of healthcare equipment and devices available across various centers.

Devanand Patil 2021-11-11
img

Intravascular Ultrasound (IVUS) Devices Market: IntroductionAccording to the report, the global intravascular ultrasound (IVUS) devices market was valued at US$ 600 Mn in 2020.

It helps to determine the amount of plaque buildup in a vessel and its composition.

Rise in the need of IVUS procedures during PCI procedures and increase in the adoption of IVUS systems in hospitals and diagnostic centers are key factors that are likely to drive the global intravascular ultrasound (IVUS) devices market during the forecast period.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=2208North America held a major share of the global intravascular ultrasound (IVUS) devices market in 2020, owing to the availability of skilled doctors, well-established healthcare facilities, and high healthcare expenditure.

The intravascular ultrasound (IVUS) devices market in Asia Pacific is projected to expand at a notable CAGR of 8.5% from 2021 to 2031, owing to a surge in patient pool and rise in adoption of technologically advanced diagnostic equipment.High Incidence Rate of Cardiovascular Disorders to Drive MarketAccording to the statistics reported by WHO, cardiovascular diseases are the number one cause of death, accounting for nearly 17.9 million deaths globally every year.

The primary causes of high incidence of cardiovascular diseases include diabetes, smoking, hyperlipidemia, hypertension, obesity, poor nutrition, and lack of physical activity.

The IVUS consoles segment dominated the market in 2020, owing to rise in the demand for intravascular ultrasound consoles assisted cardiovascular surgeries.Need of Intravascular Ultrasound (IVUS) Devices in Coronary InterventionIn terms of application, the global intravascular ultrasound (IVUS)   has been classified into coronary diagnosis, coronary intervention, coronary research, and non-coronary/peripheral applications.

Devanand Patil 2021-11-11
img

Newborn Screening Market: IntroductionAccording to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031.

Newborn screening helps in the early detection of serious genetic diseases, which may result in disability or death if not treated at the initial stage.

Different types of instrument and assay kits are used in the diagnosis of newborn disorders.

Hearing screening devices and pulse oximeter are regularly used in the diagnosis of newborn disorders.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=4581The growth of the global newborn screening market can be ascribed to the rise in prevalence of critical congenital heart defects and government support.

The U.S. has a national program of newborn screening tests to check for several different disorders that can be treated, if found very early in life.North America dominated the global newborn screening market in 2019.

According to the Indian Academy of Pediatrics, more than 200,000 children are estimated to be born with CHD in India every year.